Unknown

Dataset Information

Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals.


ABSTRACT:

Background

Despite healthcare professionals (HCP) endorsing the clinical utility of pharmacogenomics testing, use in clinical practice is limited.

Aims

To assess HCP' perceptions of pharmacogenomic testing and identify barriers to implementation.

Methods

HCP involved in prescribing decisions at three hospitals in Sydney, Australia, were invited to participate. The online survey assessed perceptions of pharmacogenomic testing, including: (i) demographic and practice variables; (ii) use, knowledge and confidence; (iii) perceived benefits; (iv) barriers to implementation; and (v) operational and/or system changes and personnel required to implement on site.

Results

HCP were predominantly medical practitioners (75/107) and pharmacists (25/107). HCP perceived pharma

SUBMITTER: Pearce A 

PROVIDER: S-EPMC9541847 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature